Dexcom (DXCM) EPS (Diluted) Growth (3y) (2016 - 2026)
Dexcom (DXCM) EPS (Diluted) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.43% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 7.66% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 62.91% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 63.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 30.57% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 29.56% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.42% |
| Dec 31, 2025 | 45.33% |
| Sep 30, 2025 | 43.11% |
| Jun 30, 2025 | 53.92% |
| Mar 31, 2025 | 4.46% |
| Dec 31, 2024 | 209.93% |
| Sep 30, 2024 | 14.75% |
| Jun 30, 2024 | 20.50% |
| Mar 31, 2024 | 35.22% |
| Dec 31, 2023 | -17.03% |
| Sep 30, 2023 | 15.95% |
| Jun 30, 2023 | 31.05% |
| Mar 31, 2023 | 29.99% |
| Dec 31, 2022 | -5.08% |
| Sep 30, 2022 | 24.29% |
| Jun 30, 2022 | 83.63% |
| Mar 31, 2022 | 71.53% |
| Dec 31, 2021 | 70.38% |
| Sep 30, 2021 | 18.96% |
| Jun 30, 2021 | 32.58% |